Medical Devices

Consumer-oriented medical device and pharmaceutical information

Medical Device Industry Regulatory and Quality Consultants

The consultants at Medical Devices and Pharma have decades of aggregated experience working with a variety of medical devices. That includes expert knowledge of regulations from the U.S. Food and Drug Administration (FDA), Health Canada (HC), the European Union (EU) and other global regulatory bodies.

We offer current information about new and novel medical devices, device safety alerts, industry news, and enforcement actions like FDA warning letters. Our regulatory specialists can expertly compile, prepare, and submit regulatory submissions for regulatory marketing authorization, like an FDA 510(k) premarket submission.

What is a medical device?

The definition of a medical device encompasses a wide range of complexity and purposes, from a walking cane to an artificial heart. It can be a physical apparatus or something like software or a chemical reagent.

Regardless of its form or composition, a product is defined as a medical device if it is used to diagnose a medical issue; alleviate, prevent or minimize the risk of a medical problem; or to provide medical treatment.

The differences between medical devices and pharmaceuticals.

Is your product a medical device?

Let us answer your questions about your medical device product, from device classification and requirements to establishment registration and device listings and requirements you need to follow in order to market the product in the U.S. Click here to contact us.

FDA definition of a medical device

An instrument, apparatus, implement, machine, contrivance, implant, in vitro reagent, or other similar or related article, including a component part or accessory which is:

  1. Recognized in the official National Formulary, or the United States Pharmacopoeia, or any supplement to them,
  2. Intended for use in the diagnosis of disease or other conditions, or in the cure, mitigation, treatment, or prevention of disease, in man or other animals, or
  3. Intended to affect the structure or any function of the body of man or other animals, and which does not achieve its primary intended purposes through chemical action within or on the body of man or other animals and
  4. Which does not achieve its primary intended purposes through chemical action within or on the body of man or other animals and which is not dependent upon being metabolized for the achievement of its primary intended purposes.

The term “device” does not include software functions excluded pursuant to section 520(o). Source: “Is the Product a Medical Device?“

Pre-amendment and post-amendment devices

Devices are also identified as pre-amendment or post-amendment based on when they received FDA market clearance. This makes a difference for how a manufacturer can put a device on the U.S. market.

Pre-amendment devices were on the market prior to the enactment of the Medical Device Amendments (MDA) of the Food, Drug and Cosmetic Act on May 28, 1976. They do not require a premarket approval (PMA) or premarket notification (510(k)) submission prior to market entry.

Post-amendment devices received marketing approval after the enactment of the MDA in 1976. Class III devices require the FDA approval of a PMA before the device can be sold on the market. Most class II and some class I devices require a 510(k) premarket notification submission to demonstrate that they are substantially equivalent to a medical device that is currently marketed in the U.S.

Medical Devices
Combination Products
Medical Device Alerts Bold 1
Medical Device Warning Letters

Medical Device Headlines

Intersurgical 22mm Smoothbore Breathing Tubes and Systems

FDA Issues Early Alert for Intersurgical Breathing Systems Over Potential Ventilation Failure. Manufacturing defect may cause breathing tube connectors to separate during use, potentially interrupting ventilation and exposing patients to serious injury or death.The...

FDA Early Alert: Teleflex/Arrow Guidewire

Affected guidewires and catheter products may release hydrophilic polymer particles into the bloodstream, potentially causing serious injury or death. No serious injuries or deaths have been reported.The U.S. Food and Drug Administration (FDA) has issued an Early...

Class 1 Recall for HemosIL AcuStar HIT Antibody Test

HemosIL AcuStar HIT-IgG(PF4-H). Source: fda.govPerformance problems could produce false-negative results, potentially delaying diagnosis of a dangerous reaction to heparin.The U.S. Food and Drug Administration (FDA) has identified a recall of certain lots of the...

Closing the Arterial Opening Without Surgery

Vivasure Medical's PerQseal Elite offers a minimally invasive approach to closing large arterial openings following cardiovascular procedures.Vivasure Medical's PerQseal Elite offers a minimally invasive approach to closing large arterial openings following...

FDA Approves Amplatzer Paraclose for Heart Valve Leaks

Abbott's Amplatzer Paraclose PVL Occluder offers a minimally invasive alternative for patients who develop a significant complication following heart valve replacement surgery.Heart valve replacement surgery can be lifesaving for patients with damaged or diseased...

October 2026 Premarket Approval (PMA) Authorizations

Three original device approvals and 218 supplements / noticesFDA's October activity highlights three newly approved medical devices and the extensive regulatory oversight required to maintain and modify products already on the market.The U.S. Food and Drug...

A Heart Valve Designed to Grow with Children

The new pediatric heart valve could reduce the need for repeat surgeries, but FDA requires additional studies to establish its long-term benefits.Children born with certain heart conditions may face multiple surgeries as they grow. One reason is surprisingly simple:...

October 2026 FDA Premarket Notification Clearances

510(k) Clearances – Robotics, AI and Diagnostics Lead the WatchlistOverview FDA issued 295 premarket notification clearance decisions during October of 2026 The records include 293 K-numbered submissions and two BK-numbered donor-testing submissions, all with decision...

FDA Clears AI Software for Automated Kidney Volume Assessment

AIRA uses artificial intelligence to analyze CT images and measure kidney volume, offering clinicians an automated tool for renal assessment. FDA Authorization Item Information Device Artificial Intelligence Renal Assessment (AIRA) Version 1 Manufacturer Aramis Global...

FDA Approves SELUTION SLR Drug-Eluting Balloon

SELUTION SLR Drug-Eluting Balloon. Source: MedAlliance LLCNew PMA approval introduces a sirolimus-eluting balloon treatment for coronary arteries, supported by randomized clinical evidence and ongoing post-approval surveillance. FDA approved the SELUTION SLR™ 014 PTCA...